A novel model to culture cells from giant cell tumor of bone using three‐dimensional (3D) polycaprolactone scaffold
Two‐dimensional (2D) culture of cells from giant cell tumor of bone (GCTB) is affected by loss of the multinucleated giant cells in subsequent passages. Therefore, there is limited time to study GCTB with all its histological components in 2D culture. Here, we explored the possibility of culturing G...
Saved in:
Published in | Engineering in life sciences Vol. 21; no. 8-9; pp. 539 - 543 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Germany
John Wiley & Sons, Inc
01.09.2021
John Wiley and Sons Inc Wiley-VCH |
Subjects | |
Online Access | Get full text |
ISSN | 1618-0240 1618-2863 |
DOI | 10.1002/elsc.202100020 |
Cover
Abstract | Two‐dimensional (2D) culture of cells from giant cell tumor of bone (GCTB) is affected by loss of the multinucleated giant cells in subsequent passages. Therefore, there is limited time to study GCTB with all its histological components in 2D culture. Here, we explored the possibility of culturing GCTB cells on a polycaprolactone (PCL)‐printed scaffold. We also evaluated the viability of the cultured cells and their adherence to the PCL scaffold at day 14 days using immunofluorescence analysis with calcein, vinculin, and phalloidin. Using the histological technique with hematoxylin and eosin staining, we observed all the histological components of GCTB in this 3D model. Immunohistochemical assays with cathepsin K, p63, and receptor activator of nuclear factor (NF)‐κB ligand (RANKL) yielded positive results in this construct, which allowed us to confirm that the seeded cells maintained the expression of GCTB markers. Based on these findings, we concluded that the PCL scaffold is an efficient model to culture GCTB cells, and the cell viability and adherence to the scaffold can be preserved for up to 14 days. Moreover, this model can also be used in subsequent studies to assess in vitro cell–cell interactions and antineoplastic efficacy of certain agents to establish a treatment against GCTB. |
---|---|
AbstractList | Abstract Two‐dimensional (2D) culture of cells from giant cell tumor of bone (GCTB) is affected by loss of the multinucleated giant cells in subsequent passages. Therefore, there is limited time to study GCTB with all its histological components in 2D culture. Here, we explored the possibility of culturing GCTB cells on a polycaprolactone (PCL)‐printed scaffold. We also evaluated the viability of the cultured cells and their adherence to the PCL scaffold at day 14 days using immunofluorescence analysis with calcein, vinculin, and phalloidin. Using the histological technique with hematoxylin and eosin staining, we observed all the histological components of GCTB in this 3D model. Immunohistochemical assays with cathepsin K, p63, and receptor activator of nuclear factor (NF)‐κB ligand (RANKL) yielded positive results in this construct, which allowed us to confirm that the seeded cells maintained the expression of GCTB markers. Based on these findings, we concluded that the PCL scaffold is an efficient model to culture GCTB cells, and the cell viability and adherence to the scaffold can be preserved for up to 14 days. Moreover, this model can also be used in subsequent studies to assess in vitro cell–cell interactions and antineoplastic efficacy of certain agents to establish a treatment against GCTB. Two-dimensional (2D) culture of cells from giant cell tumor of bone (GCTB) is affected by loss of the multinucleated giant cells in subsequent passages. Therefore, there is limited time to study GCTB with all its histological components in 2D culture. Here, we explored the possibility of culturing GCTB cells on a polycaprolactone (PCL)-printed scaffold. We also evaluated the viability of the cultured cells and their adherence to the PCL scaffold at day 14 days using immunofluorescence analysis with calcein, vinculin, and phalloidin. Using the histological technique with hematoxylin and eosin staining, we observed all the histological components of GCTB in this 3D model. Immunohistochemical assays with cathepsin K, p63, and receptor activator of nuclear factor (NF)-κB ligand (RANKL) yielded positive results in this construct, which allowed us to confirm that the seeded cells maintained the expression of GCTB markers. Based on these findings, we concluded that the PCL scaffold is an efficient model to culture GCTB cells, and the cell viability and adherence to the scaffold can be preserved for up to 14 days. Moreover, this model can also be used in subsequent studies to assess in vitro cell-cell interactions and antineoplastic efficacy of certain agents to establish a treatment against GCTB.Two-dimensional (2D) culture of cells from giant cell tumor of bone (GCTB) is affected by loss of the multinucleated giant cells in subsequent passages. Therefore, there is limited time to study GCTB with all its histological components in 2D culture. Here, we explored the possibility of culturing GCTB cells on a polycaprolactone (PCL)-printed scaffold. We also evaluated the viability of the cultured cells and their adherence to the PCL scaffold at day 14 days using immunofluorescence analysis with calcein, vinculin, and phalloidin. Using the histological technique with hematoxylin and eosin staining, we observed all the histological components of GCTB in this 3D model. Immunohistochemical assays with cathepsin K, p63, and receptor activator of nuclear factor (NF)-κB ligand (RANKL) yielded positive results in this construct, which allowed us to confirm that the seeded cells maintained the expression of GCTB markers. Based on these findings, we concluded that the PCL scaffold is an efficient model to culture GCTB cells, and the cell viability and adherence to the scaffold can be preserved for up to 14 days. Moreover, this model can also be used in subsequent studies to assess in vitro cell-cell interactions and antineoplastic efficacy of certain agents to establish a treatment against GCTB. Two-dimensional (2D) culture of cells from giant cell tumor of bone (GCTB) is affected by loss of the multinucleated giant cells in subsequent passages. Therefore, there is limited time to study GCTB with all its histological components in 2D culture. Here, we explored the possibility of culturing GCTB cells on a polycaprolactone (PCL)-printed scaffold. We also evaluated the viability of the cultured cells and their adherence to the PCL scaffold at day 14 days using immunofluorescence analysis with calcein, vinculin, and phalloidin. Using the histological technique with hematoxylin and eosin staining, we observed all the histological components of GCTB in this 3D model. Immunohistochemical assays with cathepsin K, p63, and receptor activator of nuclear factor (NF)-κB ligand (RANKL) yielded positive results in this construct, which allowed us to confirm that the seeded cells maintained the expression of GCTB markers. Based on these findings, we concluded that the PCL scaffold is an efficient model to culture GCTB cells, and the cell viability and adherence to the scaffold can be preserved for up to 14 days. Moreover, this model can also be used in subsequent studies to assess in vitro cell-cell interactions and antineoplastic efficacy of certain agents to establish a treatment against GCTB. |
Audience | Academic |
Author | Meneses‐García, Abelardo Landa‐Solís, Carlos Estrada‐Villaseñor, Eréndira Valdés‐Flores, Margarita Pichardo‐Bahena, Raul Delgado‐Cedillo, Ernesto D. Silva‐Bermudez, Phaedra Ostoa‐Saloma, Pedro Olivos‐Meza, Anell Mercado‐Celis, Gabriela |
AuthorAffiliation | 1 Pathology Service National Institute of Rehabilitation Luis Guillermo Ibarra Ibarra Mexico City Mexico 5 Department of Immunology Institute of Biomedical Research National Autonomous University of Mexico Mexico City Mexico 6 Laboratory of Clinical Genomics Division of Graduate Studies and Research Faculty of Odontology National Autonomous University of Mexico Mexico City Mexico 3 Pathology Service National Cancer Institute Mexico City Mexico 2 Genetics Laboratory National Institute of Rehabilitation Luis Guillermo Ibarra Ibarra Mexico City Mexico 4 Tissue Engineering and Cell Therapy Unit National Institute of Rehabilitation Luis Guillermo Ibarra Ibarra Mexico City Mexico 7 Bone Tumors Service National Institute of Rehabilitation Luis Guillermo Ibarra Ibarra Mexico City Mexico 8 Sports Orthopedics and Arthroscopy National Institute of Rehabilitation Luis Guillermo Ibarra Ibarra Mexico City Mexico |
AuthorAffiliation_xml | – name: 5 Department of Immunology Institute of Biomedical Research National Autonomous University of Mexico Mexico City Mexico – name: 3 Pathology Service National Cancer Institute Mexico City Mexico – name: 8 Sports Orthopedics and Arthroscopy National Institute of Rehabilitation Luis Guillermo Ibarra Ibarra Mexico City Mexico – name: 7 Bone Tumors Service National Institute of Rehabilitation Luis Guillermo Ibarra Ibarra Mexico City Mexico – name: 2 Genetics Laboratory National Institute of Rehabilitation Luis Guillermo Ibarra Ibarra Mexico City Mexico – name: 6 Laboratory of Clinical Genomics Division of Graduate Studies and Research Faculty of Odontology National Autonomous University of Mexico Mexico City Mexico – name: 1 Pathology Service National Institute of Rehabilitation Luis Guillermo Ibarra Ibarra Mexico City Mexico – name: 4 Tissue Engineering and Cell Therapy Unit National Institute of Rehabilitation Luis Guillermo Ibarra Ibarra Mexico City Mexico |
Author_xml | – sequence: 1 givenname: Eréndira surname: Estrada‐Villaseñor fullname: Estrada‐Villaseñor, Eréndira organization: National Institute of Rehabilitation Luis Guillermo Ibarra Ibarra – sequence: 2 givenname: Margarita surname: Valdés‐Flores fullname: Valdés‐Flores, Margarita organization: National Institute of Rehabilitation Luis Guillermo Ibarra Ibarra – sequence: 3 givenname: Abelardo surname: Meneses‐García fullname: Meneses‐García, Abelardo organization: National Cancer Institute – sequence: 4 givenname: Phaedra surname: Silva‐Bermudez fullname: Silva‐Bermudez, Phaedra organization: National Institute of Rehabilitation Luis Guillermo Ibarra Ibarra – sequence: 5 givenname: Raul surname: Pichardo‐Bahena fullname: Pichardo‐Bahena, Raul organization: National Institute of Rehabilitation Luis Guillermo Ibarra Ibarra – sequence: 6 givenname: Pedro surname: Ostoa‐Saloma fullname: Ostoa‐Saloma, Pedro organization: National Autonomous University of Mexico – sequence: 7 givenname: Gabriela surname: Mercado‐Celis fullname: Mercado‐Celis, Gabriela organization: National Autonomous University of Mexico – sequence: 8 givenname: Ernesto D. surname: Delgado‐Cedillo fullname: Delgado‐Cedillo, Ernesto D. organization: National Institute of Rehabilitation Luis Guillermo Ibarra Ibarra – sequence: 9 givenname: Anell surname: Olivos‐Meza fullname: Olivos‐Meza, Anell organization: National Institute of Rehabilitation Luis Guillermo Ibarra Ibarra – sequence: 10 givenname: Carlos orcidid: 0000-0002-0680-8516 surname: Landa‐Solís fullname: Landa‐Solís, Carlos email: clanda@inr.gob.mx organization: National Institute of Rehabilitation Luis Guillermo Ibarra Ibarra |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34584518$$D View this record in MEDLINE/PubMed |
BookMark | eNqFksuO0zAUhiM0iLnAliWyxGZYtPiauBukqgwwUiUWwNpyfOl45MTFdgZ1xyPwjDwJTtvpUARCkXI5-c5_zvl9zquTPvSmqp4jOEUQ4tfGJzXFEJcPiOGj6gzViE8wr8nJ_h1iCk-r85RuIUQN5-hJdUoo45QhflYNc9CHO-NBF3S55wDU4PMQDVDG-wRsDB1YOdnnbQDkoQsRBAva0gcYkutXIN9EY35-_6FdZ_rkQi89uCRvX4F18Bsl1zF4qfLIJyWtDV4_rR5b6ZN5tn9eVF_eXX1efJgsP76_XsyXE8VYTSamwXhmcUtaVFs1UzWTSrXYGNQ0kkuqMYdStbRFEBPdasu15IwaSWpjuCXkorre6eogb8U6uk7GjQjSiW0gxJWQMTvljWhY8YRpCDmTlBHNOaczNpN1EWvhjBetNzut9dB2RivT5yj9kejxn97diFW4E8XpmuCxmcu9QAxfB5Oy6FwaTZW9CUMSmDVNQzBEsKAv_0BvwxCLr1uKFQQz_ECtZBnA9TaUumoUFfMGQdZASMey079Q5dKmc6qcinUlfpTw4vdBDxPeL00B6A5QMaQUjRXKZZnLwRdl5wWCYtxNMe6mOOzmQyOHtHvlfybs63wrHW7-Q4ur5acFosXnX2yp9aI |
CitedBy_id | crossref_primary_10_1021_acsabm_3c00441 crossref_primary_10_3390_app131810177 |
Cites_doi | 10.1088/1748-605X/aa51d5 10.1073/pnas.1221403110 10.1155/2017/8074890 10.1007/s004320100234 10.1038/modpathol.3801023 10.18632/oncotarget.4223 10.1097/00003086-199009000-00036 10.1002/biot.201400277 10.1016/j.bone.2012.10.002 10.1172/JCI110919 10.1016/j.biotechadv.2014.07.009 10.3109/03008207.2013.848202 10.1016/S0002-9440(10)63323-8 |
ContentType | Journal Article |
Copyright | 2021 The Authors. published by Wiley‐VCH GmbH 2021 The Authors. Engineering in Life Sciences published by Wiley‐VCH GmbH. COPYRIGHT 2021 John Wiley & Sons, Inc. 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: 2021 The Authors. published by Wiley‐VCH GmbH – notice: 2021 The Authors. Engineering in Life Sciences published by Wiley‐VCH GmbH. – notice: COPYRIGHT 2021 John Wiley & Sons, Inc. – notice: 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | 24P AAYXX CITATION NPM 8FE 8FG 8FH ABJCF ABUWG AFKRA AZQEC BBNVY BENPR BGLVJ BHPHI CCPQU DWQXO GNUQQ HCIFZ L6V LK8 M7P M7S PHGZM PHGZT PIMPY PKEHL PQEST PQGLB PQQKQ PQUKI PRINS PTHSS 7X8 5PM DOA |
DOI | 10.1002/elsc.202100020 |
DatabaseName | Wiley Online Library Open Access CrossRef PubMed ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Journals ProQuest Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Technology Collection Natural Science Collection ProQuest One Community College ProQuest Central ProQuest Central Student SciTech Premium Collection ProQuest Engineering Collection Biological Sciences Biological Science Database Engineering Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest Central Student Technology Collection ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Engineering Collection Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Central (New) Engineering Collection Engineering Database ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Technology Collection Biological Science Database ProQuest SciTech Collection ProQuest One Academic UKI Edition Materials Science & Engineering Collection ProQuest One Academic ProQuest One Academic (New) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed CrossRef Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Engineering |
DocumentTitleAlternate | ESTRADA‐VILLASEÑOR et al |
EISSN | 1618-2863 |
EndPage | 543 |
ExternalDocumentID | oai_doaj_org_article_754585d0085a453d8884959a6a36b098 PMC8456323 A710570043 34584518 10_1002_elsc_202100020 ELSC1423 |
Genre | shortCommunication Journal Article |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 1L6 1OC 24P 31~ 33P 3SF 3WU 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 53G 5GY 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A03 AAESR AAEVG AAFWJ AAHBH AAHHS AANHP AAONW AAZKR ABCQN ABCUV ABDBF ABEML ABIJN ABJCF ABJNI ACBWZ ACCFJ ACCMX ACGFS ACPOU ACRPL ACSCC ACUHS ACXQS ACYXJ ADBBV ADEOM ADIZJ ADMGS ADNMO ADZOD AEEZP AEIMD AENEX AEQDE AEUQT AFBPY AFGKR AFKRA AFPKN AFPWT AFZJQ AIURR AIWBW AJBDE AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR ASPBG ATUGU AUFTA AVWKF AZBYB AZFZN AZVAB BAFTC BBNVY BDRZF BENPR BFHJK BGLVJ BHBCM BHPHI BMNLL BMXJE BNHUX BROTX BRXPI BY8 CCPQU CS3 D-E D-F DCZOG DPXWK DR2 DU5 EBD EBS EJD F00 F01 F04 FEDTE G-S G.N GNP GODZA GROUPED_DOAJ H.T H.X HCIFZ HF~ HHY HVGLF HZ~ IAO IGS ITC IX1 J0M JPC KQQ LAW LC2 LC3 LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M7P M7S MK4 MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 P2P P2W P2X P4D PIMPY PTHSS Q.N Q11 QB0 R.K ROL RPM RWI RX1 SUPJJ TUS UB1 W8V W99 WBKPD WIH WIK WIN WNSPC WOHZO WQJ WRC WYISQ XG1 XV2 ZZTAW ~IA ~WT AAYXX AGQPQ CITATION IEP PHGZM PHGZT NPM PMFND 8FE 8FG 8FH AAMMB ABUWG AEFGJ AGXDD AIDQK AIDYY AZQEC DWQXO GNUQQ L6V LK8 PKEHL PQEST PQGLB PQQKQ PQUKI PRINS 7X8 PUEGO 5PM |
ID | FETCH-LOGICAL-c5563-e7229f2b3b16fc9c65accb2ee177a8a4d280acb4b1023dbdf8da854ea36ee8f33 |
IEDL.DBID | BENPR |
ISSN | 1618-0240 |
IngestDate | Wed Aug 27 01:23:24 EDT 2025 Thu Aug 21 18:45:51 EDT 2025 Thu Sep 04 23:10:18 EDT 2025 Wed Aug 13 06:08:04 EDT 2025 Tue Jun 17 21:37:32 EDT 2025 Tue Jun 10 20:49:26 EDT 2025 Wed Feb 19 02:09:02 EST 2025 Tue Jul 01 01:15:38 EDT 2025 Thu Apr 24 23:12:29 EDT 2025 Wed Jan 22 16:28:53 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8-9 |
Keywords | 3D tumor models 3D PCL scaffold giant cell tumor of bone |
Language | English |
License | Attribution 2021 The Authors. Engineering in Life Sciences published by Wiley‐VCH GmbH. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c5563-e7229f2b3b16fc9c65accb2ee177a8a4d280acb4b1023dbdf8da854ea36ee8f33 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-0680-8516 |
OpenAccessLink | https://www.proquest.com/docview/2575010252?pq-origsite=%requestingapplication%&accountid=15518 |
PMID | 34584518 |
PQID | 2575010252 |
PQPubID | 5069930 |
PageCount | 5 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_754585d0085a453d8884959a6a36b098 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8456323 proquest_miscellaneous_2577732010 proquest_journals_2575010252 gale_infotracmisc_A710570043 gale_infotracacademiconefile_A710570043 pubmed_primary_34584518 crossref_citationtrail_10_1002_elsc_202100020 crossref_primary_10_1002_elsc_202100020 wiley_primary_10_1002_elsc_202100020_ELSC1423 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | September 2021 |
PublicationDateYYYYMMDD | 2021-09-01 |
PublicationDate_xml | – month: 09 year: 2021 text: September 2021 |
PublicationDecade | 2020 |
PublicationPlace | Germany |
PublicationPlace_xml | – name: Germany – name: Weinheim – name: Hoboken |
PublicationTitle | Engineering in life sciences |
PublicationTitleAlternate | Eng Life Sci |
PublicationYear | 2021 |
Publisher | John Wiley & Sons, Inc John Wiley and Sons Inc Wiley-VCH |
Publisher_xml | – name: John Wiley & Sons, Inc – name: John Wiley and Sons Inc – name: Wiley-VCH |
References | 2004; 165 2015; 6 1990; 258 2017; 2017 2013; 54 2013; 52 2017; 12 1983; 71 2008; 21 2013; 110 2014; 9 2014; 32 2001; 127 e_1_2_6_10_1 Komiya S. (e_1_2_6_5_1) 1990; 258 e_1_2_6_9_1 e_1_2_6_8_1 e_1_2_6_4_1 e_1_2_6_7_1 e_1_2_6_6_1 e_1_2_6_13_1 e_1_2_6_14_1 e_1_2_6_3_1 e_1_2_6_11_1 e_1_2_6_2_1 e_1_2_6_12_1 |
References_xml | – volume: 127 start-page: 467 year: 2001 end-page: 474 article-title: The nature of giant cell tumor of bone publication-title: J Cancer Res Clin Oncol – volume: 32 start-page: 1256 year: 2014 end-page: 1268 article-title: Three‐dimensional in vitro tumor models for cancer research and drug evaluation publication-title: Biotechnol Adv – volume: 71 start-page: 1633 year: 1983 end-page: 1648 article-title: Delineation of four cell types comprising the giant cell tumor of bone. Expression of Ia and monocyte‐macrophage lineage antigens publication-title: J Clin Invest – volume: 258 start-page: 304 year: 1990 end-page: 309 article-title: Characterization of cells cultured from human giant‐cell tumors of bone. Phenotypic relationship to the monocyte‐macrophage and osteoclast publication-title: Clin Orthop Relat Res – volume: 110 start-page: 6500 year: 2013 end-page: 6505 article-title: Modeling Ewing sarcoma tumors in vitro with 3D scaffolds publication-title: Proc Natl Acad Sci U S A – volume: 9 start-page: 1312 year: 2014 end-page: 1321 article-title: Biosilica‐loaded poly(ε‐caprolactone) nanofibers mats provide a morphogenetically active surface scaffold for the growth and mineralization of the osteoclast‐related SaOS‐2 cells publication-title: Biotechnol J – volume: 12 issue: 1 year: 2017 article-title: Effects of different sterilization methods on the physico‐chemical and bioresponsive properties of plasma‐treated polycaprolactone films publication-title: Biomed Mater – volume: 21 start-page: 531 year: 2008 end-page: 539 article-title: Gene expression profiling identifies p63 as a diagnostic marker for giant cell tumor of the bone publication-title: Mod Pathol – volume: 54 start-page: 439 year: 2013 end-page: 449 article-title: Comparison of the anti‐tumor effects of denosumab and zoledronic acid on the neoplastic stromal cells of giant cell tumor of bone publication-title: Connect Tissue Res – volume: 2017 year: 2017 article-title: Application of synthetic polymeric scaffolds in breast cancer 3D tissue cultures and animal tumor models publication-title: Int J Biomater – volume: 6 start-page: 18980 year: 2015 end-page: 18996 article-title: MicroRNA‐106b inhibits osteoclastogenesis and osteolysis by targeting RANKL in giant cell tumor of bone publication-title: Oncotarget – volume: 165 start-page: 593 year: 2004 end-page: 600 article-title: Cathepsin K is the principal protease in giant cell tumor of bone publication-title: Am J Pathol – volume: 52 start-page: 238 year: 2013 end-page: 246 article-title: Giant cell tumor of bone: a basic science perspective publication-title: Bone – ident: e_1_2_6_11_1 doi: 10.1088/1748-605X/aa51d5 – ident: e_1_2_6_10_1 doi: 10.1073/pnas.1221403110 – ident: e_1_2_6_9_1 doi: 10.1155/2017/8074890 – ident: e_1_2_6_2_1 doi: 10.1007/s004320100234 – ident: e_1_2_6_12_1 doi: 10.1038/modpathol.3801023 – ident: e_1_2_6_14_1 doi: 10.18632/oncotarget.4223 – volume: 258 start-page: 304 year: 1990 ident: e_1_2_6_5_1 article-title: Characterization of cells cultured from human giant‐cell tumors of bone. Phenotypic relationship to the monocyte‐macrophage and osteoclast publication-title: Clin Orthop Relat Res doi: 10.1097/00003086-199009000-00036 – ident: e_1_2_6_8_1 doi: 10.1002/biot.201400277 – ident: e_1_2_6_3_1 doi: 10.1016/j.bone.2012.10.002 – ident: e_1_2_6_4_1 doi: 10.1172/JCI110919 – ident: e_1_2_6_7_1 doi: 10.1016/j.biotechadv.2014.07.009 – ident: e_1_2_6_6_1 doi: 10.3109/03008207.2013.848202 – ident: e_1_2_6_13_1 doi: 10.1016/S0002-9440(10)63323-8 |
SSID | ssj0017881 |
Score | 2.275511 |
Snippet | Two‐dimensional (2D) culture of cells from giant cell tumor of bone (GCTB) is affected by loss of the multinucleated giant cells in subsequent passages.... Two-dimensional (2D) culture of cells from giant cell tumor of bone (GCTB) is affected by loss of the multinucleated giant cells in subsequent passages.... Abstract Two‐dimensional (2D) culture of cells from giant cell tumor of bone (GCTB) is affected by loss of the multinucleated giant cells in subsequent... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref wiley |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 539 |
SubjectTerms | 3D PCL scaffold 3D tumor models Analysis Calcein Carbon dioxide Cathepsin K Cathepsins Cell adhesion & migration Cell culture Cell interactions Cell viability Cytokines Ewings sarcoma giant cell tumor of bone Giant cells Immunofluorescence Phalloidin Polycaprolactone Protein expression Proteins Scaffolds Short Communication Three dimensional models TRANCE protein Tumors Vinculin |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQT3BAvAkUZCQk4BA1sWM7OS6lVYWAC1TqzXL8KEghqbpZJG78BH4jv4QZOxttQKgXrvY4fszYM86MvyHkeeCSe2brXHILFxQubN44YXJQXpWyoO9dwNfI7z_Ik9Pq7Zk420n1hTFhCR44LdyBQs-OcGgamEpwBzc2sOkbIw2XbdHEZ75FU2wvU5P_AEHS8aolyzpHFK8tXGPBDkDlIHQhK6MXbqGOImr_32fzjnL6M3By16CNGun4Frk5mZJ0laZwm1zz_R1yYwdg8C7ZrGg_fPMdjQlv6DjQhLThKf6wX1N8XELPQULGWEDHzdfhkg6BtkPvKcbEn9MRuO1__fjpMA9AwvCgL_mbV_Ri6L5bA8PvMGcP0K-tCWHo3D1yenz06fAknxIt5BbxwXKvGGsCa3lbymAbK4WxtmXel0qZ2lSO1YWxbdUizoNrXaidqUXlgQXe14Hz-2Svh34eEhpsqMEGqphyVeWEbHzJQ42Y_R7ODuEzkm_XW9sJhRyTYXQ64SczjfzRM38y8mKmv0j4G_-kfI3sm6kQNzsWgDTpSZr0VdIE3SHzNe5uGJY10yMFmBziZOmVwrzI6D7NyP6CEnalXVZvxUdPp8Jaw_EoEMNPsIw8m6uxJUa69X7YRBqlOMYoZORBkrZ5Shyd2qKEUaqFHC7mvKzpv3yOmOHQTnIGw8qjxF6xlvro3cfDEiztR_9jUR-T6_jlFJm3T_bGy41_Aqbc2D6Nu_Y3gJpBGg priority: 102 providerName: Directory of Open Access Journals – databaseName: Wiley Online Library - Core collection (SURFmarket) dbid: DR2 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpZ1Lb9QwEIAt1BMceD8WCjISEnBI29ix4xyXPlQh4ABU6s3yc4tYkmo3iwQnfgK_kV_CjJMNmyKEEFd7rHi8kxlnPf6GkCeRSx6YU5nkDj5QuHBZ5YXJIHgVpYN47yPeRn79Rh6fFC9PxenGLf6ODzH84YZvRvLX-IIbu9z9BQ2F0IEIQpan0zRwwjmXCM8_eDvwo3JkpeMXl8xVhjCvNbVxj-2Oh4-iUoL3_-6iN2LUxfzJzX1tCkxH14hZq9Tlo3zcWbV2x329QHv8H52vk6v9rpVOOzO7QS6F-ia5ssEyvEVWU1o3n8Ocpto6tG1oB_UIFM8GlhTvsdAZGGObGmi7-tQsaBOpbepAMf1-RlswrPDj23ePJQc6XAh9xg-e0_Nm_sUZUHGO5YFAfulMjM3c3yYnR4fv94-zvqZD5hBFloWSsSoyy20uo6ucFMY5y0LIy9IoU3im9oyzhUWkhLc-Km-UKILhMgQVOb9Dtmp4zj1Co4sKtlsFK31ReCGrkPOosDxAADclwoRk699Uux54jnU35rpDNTONy6mH5ZyQp4P8eYf6-KPkCzSRQQoR3amhWcx0_8brEo8khcc9rSkE9wqmVonKSFDF7lUKHocGptGRwLSc6e9DgHKI5NLTEksw40nthGyPJMEBuHH32kR174CWGjyxQFygYBPyeOjGkZhUV4dmlWTKkmM6xITc7Sx6UInj-bnIYZblyNZHOo976g9nCU8O4yRnMK0smfJf1lIfvnq3n8Om_v4_yj8gl7Gxy_fbJlvtYhUewgaxtY-SE_gJjhheFg priority: 102 providerName: Wiley-Blackwell |
Title | A novel model to culture cells from giant cell tumor of bone using three‐dimensional (3D) polycaprolactone scaffold |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Felsc.202100020 https://www.ncbi.nlm.nih.gov/pubmed/34584518 https://www.proquest.com/docview/2575010252 https://www.proquest.com/docview/2577732010 https://pubmed.ncbi.nlm.nih.gov/PMC8456323 https://doaj.org/article/754585d0085a453d8884959a6a36b098 |
Volume | 21 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lj9MwELb2cYED4k2WpTISEnCItrXjxDkg1F1aVgiq1cJKe4scPwpSNyltisSNn8Bv5Jcw4zxoQMAlh3iseOzxzMQz_oaQJ47H3DItw5hr-EHhQoepESoE4xUlGuy9cXgb-d0sPr2I3lyKyx0ya-_CYFplqxO9ojalxjPyIxAtgfhngr1cfg6xahRGV9sSGqoprWBeeIixXbIPKlmC3O8fT2Zn511cAcHTW-jGITsC84MwhmzkI3I90-QR_P_U01uG6vckym3n1lun6U1yo3Er6biWg1tkxxa3yfUtsME7ZDOmRfnFLqgvfkOrktaoG5bi4f2a4kUTOgdpqfwLWm2uyhUtHc3LwlLMj5_TClbe_vj23WBNgBrPgz7jr57TZbn4qhUMf4H1e4B-rZVz5cLcJRfTyYeT07ApuhBqxAoLbcJY6ljO81HsdKpjAXObM2tHSaKkigyTQ6XzKEfMB5MbJ42SIrKKx9ZKx_k9slfAdx4Q6rST4A9FLDFRZESc2hF3EvH7LegRYQMStvOd6QaRHAtjLLIaS5lluD5Ztz4BedrRL2ssjr9SHuPydVSIoe1flKt51mzJLMGYoTDodKpIcCNhaKlIVQys5MNUwudw8TPc6TAsrZoLC8AcYmZl4wRrJGMoNSCHPUrYobrf3IpP1miIdfZLngPyuGvGnpj1Vthy42mShGO-QkDu19LWscQxwA2iHpCkJ4c9nvstxaePHj8c-sWcwbBCL7H_mcts8vb9yQi87oN_s_GQXMM-df7dIdmrVhv7CBy2Kh-QXRadwVNOXw-aHTnwhx_4PGc_AdAzQtI |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF5V6QE4IN4YCiwSCDhYTXa9fhwqlLapUppGCFqpt2W9j4AU7JA4oN74Cfwifgy_hBnbMTEIOPXqnbX3MTsz65n5hpAnjofcMh37IddwQeFC-4kRygflFUQa9L1xmI18PA6Hp8GrM3G2Qb6vcmEwrHIlE0tBbXKN_8i3gbUE4p8J9nL2yceqUehdXZXQUHVpBbNTQozViR1H9vwLXOEWO4f7sN9PGTsYnOwN_brKgK8RHMu3EWOJYylPe6HTiQ4FvCxl1vaiSMUqMCzuKp0GKYIcmNS42KhYBFbx0NrY4Q9RUAGbAWa4dsjm7mD8-k3jx0Cw9hVUZJdtg7pD2ETWKz2ALVVYVgz4Uy-sKcbfgzbXjelSGx5cI1drM5b2K767TjZsdoNcWQM3vEmWfZrln-2UlsV2aJHTCuXDUnQWLCgmttAJcGdRPqDF8mM-p7mjaZ5ZivH4E1oAp9kfX78ZrEFQ4YfQ53z_BZ3l03OtYPhTrBcE9AutnMun5hY5vZDlv006GXznLqFOuxjsr4BFJgiMCBPb4y7GegEW5JawHvFX6y11jYCOhTimssJuZhL3Rzb745FnDf2swv74K-Uubl9DhZjd5YN8PpG1CJAR-iiFQSNXBYKbGIaWiESFMJW0m8TwOdx8iZIFhqVVnSABk0OMLtmPsCYzum49stWiBImg280r9pG1RFrIX-fHI4-bZuyJUXaZzZclTRRxjI_wyJ2K25opcXSow9HySNTiw9ac2y3Zh_clXjn0CzmDYfklx_5nLeVg9HavB1b-vX9P4xG5NDw5HsnR4fjoPrmM_avYvy3SKeZL-wCMxSJ9WJ9ISt5dtBD4CU_rffg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF5VrYTggHhjKLBIIOBgJdn1-nGoUNokammJKqBSb9v1PgJSsEPigHrjJ_C7-Bn8EmZsx8Qg4NSrd9bex3hm7Jn9PkKeOB5yy3Tsh1zDBwoX2k-MUD44ryDS4O-Nw9PIr8fh_knw6lScbpDvq7MwWFa5somloTa5xn_kHVAtgfhngnVcXRZxPBi9nH3ykUEKM60rOg1V0yyYnRJurD7kcWjPv8Dn3GLnYAB7_5Sx0fDd3r5fMw74GoGyfBsxljiW8rQXOp3oUMDNUmZtL4pUrALD4q7SaZAi4IFJjYuNikVgFQ-tjR3-HAV3sBWBlww2ydbucHz8pslpIHD7Cjayyzrg-hBCkfXKbGDLLZbsAX_6iDUn-XsB53pgXXrG0TVytQ5pab_Swetkw2Y3yJU1oMObZNmnWf7ZTmlJvEOLnFaIH5Zi4mBB8ZALnYCmFuUFWiw_5nOaO5rmmaVYmz-hBWid_fH1m0E-ggpLhD7ngxd0lk_PtYLhT5E7COQXWjmXT80tcnIhy3-bbGbwnLuEOu1iiMUCFpkgMCJMbI-7GLkDLNgwYT3ir9Zb6hoNHUk5prLCcWYS90c2--ORZ438rMIB-avkLm5fI4X43eWFfD6RtTmQEeYrhcGAVwWCmxiGlohEhTCVtJvE8DjcfIlWBoalVX1YAiaHeF2yHyE_M6ZxPbLdkgTroNvNK_WRtXVayF_vkkceN83YEyvuMpsvS5ko4lgr4ZE7lbY1U-KYXIdXyyNRSw9bc263ZB_el9jl0C_kDIbllxr7n7WUw6O3ez2I-O_9exqPyCUwBvLoYHx4n1zG7lUZ4DbZLOZL-wDixiJ9WL-QlJxdtA34CQAggiQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+novel+model+to+culture+cells+from+giant+cell+tumor+of+bone+using+three-dimensional+%283D%29+polycaprolactone+scaffold&rft.jtitle=Engineering+in+life+sciences&rft.au=Estrada-Villase%C3%B1or%2C+Er%C3%A9ndira&rft.au=Vald%C3%A9s-Flores%2C+Margarita&rft.au=Meneses-Garc%C3%ADa%2C+Abelardo&rft.au=Silva-Bermudez%2C+Phaedra&rft.date=2021-09-01&rft.issn=1618-0240&rft.volume=21&rft.issue=8-9&rft.spage=539&rft_id=info:doi/10.1002%2Felsc.202100020&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1618-0240&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1618-0240&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1618-0240&client=summon |